Search Count: 3
 |
Crystal Structure Of Human Dihydroorotate Dehydrogenase In Complex With The Inhibitor N-(3'-(2,2-Difluoropropoxy)-2,3,5,6-Tetrafluoro-[1,1'-Biphenyl]-4-Yl)-2-Hydroxypyrazolo[1,5-A]Pyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2025-07-23 Classification: OXIDOREDUCTASE Ligands: ORO, FMN, P6G, A1H8I, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-07-23
Ligands: ORO, FMN, P6G, A1H8I, SO4
 |
Crystal Structure Of Human Dihydroorotate Dehydrogenase In Complex With The Inhibitor 2-Hydroxy-N-(2-Ispropyl-5-Methyl-4-Phenoxyphenyl)Pyrazolo[1,5-A]Pyridine-3-Carboxamide.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-10-12 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, IEQ, P6G, ACT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-10-12
Ligands: FMN, ORO, IEQ, P6G, ACT
 |
Targeting Myeloid Differentiation Using Potent Human Dihydroorotate Dehydrogenase (Hdhodh) Inhibitors Based On 2-Hydroxypyrazolo[1,5-A]Pyridine Scaffold
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2018-07-11 Classification: OXIDOREDUCTASE Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-07-11
Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE